Schedule 13D ownership disclosure

Transcept Pharmaceuticals Inc

Security class unavailable

Event date: 2014-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-267819
Form type
SC 13D/A
Filer
InterWest Partners IX, LP
CIK
CIK 1398928
Filed
Jul 14, 2014
Reporting period
Jun 30, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub